Neuberger Berman Group LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 206 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
Neuberger Berman Group LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$317,000
-75.7%
9,670
-65.8%
0.00%
-100.0%
Q3 2021$1,304,000
-28.1%
28,307
-14.1%
0.00%
-50.0%
Q2 2021$1,814,000
-8.2%
32,972
-14.0%
0.00%0.0%
Q1 2021$1,976,000
+15.5%
38,332
-3.0%
0.00%0.0%
Q4 2020$1,711,000
+20.5%
39,533
-2.6%
0.00%0.0%
Q3 2020$1,420,000
-46.2%
40,581
-17.8%
0.00%
-33.3%
Q2 2020$2,641,000
+46.6%
49,391
-2.8%
0.00%0.0%
Q1 2020$1,802,000
-51.4%
50,792
-34.5%
0.00%
-25.0%
Q4 2019$3,705,000
+71.4%
77,598
+16.3%
0.00%
+33.3%
Q3 2019$2,161,000
-52.5%
66,699
-26.8%
0.00%
-40.0%
Q2 2019$4,546,000
-29.6%
91,139
-4.8%
0.01%
-37.5%
Q1 2019$6,458,000
-46.9%
95,763
-63.7%
0.01%
-52.9%
Q4 2018$12,156,000
-54.1%
263,616
-23.2%
0.02%
-43.3%
Q3 2018$26,482,000
-7.1%
343,391
+1.5%
0.03%
-3.2%
Q2 2018$28,499,000
+48.3%
338,355
+44.0%
0.03%
+40.9%
Q1 2018$19,213,000
+1972.6%
234,940
+1349.4%
0.02%
+2100.0%
Q4 2017$927,000
+24.9%
16,210
+106.1%
0.00%0.0%
Q1 2015$742,000
+186.5%
7,865
+239.6%
0.00%
Q4 2014$259,0002,3160.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Eagle Health Investments LP 431,413$12,558,0003.09%
Casdin Capital, LLC 2,090,000$60,840,0002.73%
Rock Springs Capital Management LP 2,665,275$77,586,0001.95%
Bellevue Group AG 4,129,292$120,204,0001.40%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,177,374$34,273,0001.05%
Altium Capital Management LP 66,196$1,927,0000.64%
ArrowMark Colorado Holdings LLC 1,295,948$37,725,0000.33%
FARALLON CAPITAL MANAGEMENT LLC 1,333,012$38,804,0000.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 21,500$707,0000.16%
Virtus ETF Advisers LLC 11,541$336,0000.15%
View complete list of AGIOS PHARMACEUTICALS INC shareholders